|
|
||||||||
The Journal of Immunology, Vol 146, Issue 7 2201-2206, Copyright © 1991 by American Association of Immunologists
ARTICLES |
I Berczi, E Nagy, SM de Toledo, RJ Matusik and HG Friesen
Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Hypophysectomy of Fischer 344 rats of both sexes led to a rapid involution of the thymus and spleen which was associated with a profound decrease in spontaneous DNA synthesis in these organs. The proportion of B lymphocytes in the spleen, of T cells and their subsets (CD4+/CD8+) in spleen and thymus, and the histological structure of the involuted organs remained normal. Treatment of hypophysectomized animals with growth hormone (GH) or prolactin (PRL) stimulated the expression of the c-myc proto-oncogene and DNA synthesis and reversed the involution in these organs. Replacement doses of adrenocorticotrophic hormone, follicle-stimulating hormone, luteinizing hormone, or thyroid-stimulating hormone had no influence on thymus or spleen size and DNA synthesis. A rapid expression of c-myc was also observed in thymuses and spleens of intact rats after the injection of GH or PRL. In vitro physiological concentrations (2.5 ng/ml) of either ovine or rat PRL or GH stimulated the incorporation of [3H]thymidine by thymus and spleen cells. These results indicate that GH and PRL regulate lymphocyte growth. This regulatory role is likely to serve as the principal mechanism of immunoregulation by these hormones.
This article has been cited by other articles:
![]() |
R. A. French, S. R. Broussard, W. A. Meier, C. Minshall, S. Arkins, J. F. Zachary, R. Dantzer, and K. W. Kelley Age-Associated Loss of Bone Marrow Hematopoietic Cells Is Reversed by GH and Accompanies Thymic Reconstitution Endocrinology, February 1, 2002; 143(2): 690 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text] |
||||
![]() |
J. M. Gerard, L. Garibaldi, S. E. Myers, T. Aceto JR, S. Kotagal, V. P. Gibbons, J. Stith, and C. Weber Sleep Apnea in Patients Receiving Growth Hormone Clinical Pediatrics, June 1, 1997; 36(6): 321 - 326. [Abstract] [PDF] |
||||
![]() |
M.-C. Postel-Vinay, V. de Mello Coelho, M.-C. Gagnerault, and M. Dardenne Growth Hormone Stimulates the Proliferation of Activated Mouse T Lymphocytes Endocrinology, May 1, 1997; 138(5): 1816 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |